Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...

When a patient is diagnosed with osteosarcoma, an aggressive form of bone cancer, the mission is to remove the tumor entirely ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Cancer follows a fairly standard protocol: Cells multiply out of ...

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

While genetic sequencing has previously helped to uncover different subtypes of other cancers, like breast or skin cancer, for which those patients then receive targeted treatment personalised to ...

OS Therapies’ cancer vaccine, OST-HER2, has been shown to significantly improve overall survival (OS) in patients with recurrent, fully resected, pulmonary metastatic osteosarcoma after two years.

According to DelveInsight's analysis, the market size for osteosarcoma in the 7MM is expected to grow significantly by 2034. As per DelveInsight estimates, the total incident population of ...

Osteosarcoma is a malignant neoplasm of the bone and is the most common histological form of primary bone cancer. It is most prevalent in children and young adults, as it is associated with the ...

There have been few reports of osteosarcoma after allogeneic bone marrow transplantation. 1 We report the development of osteosarcoma in a recipient 17 years after stem-cell transplantation. A ...

You don’t often hear people say that losing a limb is the best thing that could have happened. But LaQuinta Haynes, 36, of Canal Winchester, says losing her leg to cancer wasn’t an ending — it was the ...